Product categories
Transplantation
Thalassemias
Oncology
Fetal RHD screening NIPT
Hereditary
Cystic fibrosis
Cardiovascular
Male infertility
Rapid aneuploidy analysis
Accessories
Resources
Knowledge hub
Whitepapers
Tools
IFU & certificates
Company
About us
Teams
Career
News & events
Privacy policy
Legal terms
About cookies
Contact
Contact us
Our offices
Support
Distributors
For investors
For distributors
Document portal
Webshop
Knowledge hub
Join us here for a closer look at the news, research and trends shaping the diagnostic landscape.
Subscribe to our latest news & articles
Knowledge hub
Join us here for a closer look at the news, research and trends shaping the diagnostic landscape.
Filter by
All
Transplantation
Thalassemias
Oncology
Fetal RHD screening NIPT
Hereditary
Cystic fibrosis
Cardiovascular
Male infertility
Rapid aneuploidy analysis
Insights
Technology
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Insights
Rapid aneuploidy analysis
Principles of QF-PCR
QF PCR analysis includes amplification, detection and analysis of chromosome-specific DNA sequences known as genetic markers or small tandem repeats (STRs).
Insights
Rapid aneuploidy analysis
STR markers
A short tandem repeat (STR or microsatellite) is a pattern of two or more nucleotides that are repeated directly adjacent to each other.
Insights
Rapid aneuploidy analysis
X-chromosome counting markers
The Devyser QF-PCR kits includes several X-chromosome counting markers for reliable detection of Turner syndrome.
Insights
Thalassemias
Changing needs for thalassemia testing and how it will impact clinical labs
What you need to know about thalassemia prevalence and the implications for clinical laboratories.
Tips and tricks
Thalassemias
Sequence planning
Devyser offers an online Sequence Coverage Calculator to help plan your NGS run for optimal results.
Insights
Thalassemias
About Thalassemia
Thalassemias are haemoglobinopathies characterised by an abnormal haemoglobin production that can lead to anaemia and destruction of red blood cells.
Insights
Rapid aneuploidy analysis
Thrombophilia an important factor in thrombosis risk
Every year world thrombosis day is held on October 13 to bring awareness to the potential risks of developing thrombisis.
Insights
Oncology
NGS identification of both male and female cancer risks
Do you know a man who has participated at least once in “Movember”?
Insights
Oncology
CRISPR Helps BRCA1 Researchers Determine Functional And Non-Functional Mutations
BRCA1 variants may generally be divided into three categories: benign variants, which cause no clinical concern; deleterious variants
Insights
Thalassemias
CRISPR-Cas9 presents new possibilities for Thalassemia treatment.
The autosomal recessive inherited blood disorder, b-thalassemia, is caused by reduced or absent synthesis of the beta chains of hemoglobin due to mutations
Insights
Cystic fibrosis
Clinical trials highlight the importance of correct CFTR mutation detection in cystic fibrosis patients
Cystic Fibrosis is one of the most common genetic disorders.
In the media
Cardiovascular
Experts Recommend FH Genetic Testing
An expert consensus panel has recently promoted genetic testing for Familial Hypercholesterolemia (FH) as a standard of care for patients with probable FH
In the media
Oncology
New Devyser BRCA NGS study published
In this study, the Devyser BRCA test was used to analyse 227 patient DNA samples.
Insights
Rapid aneuploidy analysis
No Significant Reduction in Miscarriage Rates from NIPT Pre-Screening for Trisomy 21 as compared to invasive testing
A recent paper published by Malan et al in the Journal of the American Medical Association (JAMA) describes a clinical study
In the media
Oncology
Robust NGS workflow provides full BRCA1 & BRCA2 screening
The team at Devyser were excited to see our products put to use in a recent research project
Previous 15 Items
2 / 2